Patent · US Active

Method for remolding bone marrow microenvironment

US10493106B2 · kind B2 · utility

10Cited by
0References
16Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 12, 2018
Grant dateDec 3, 2019
Priority date
Expiry dateJan 12, 2038

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N5/0669
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention discloses a method for remolding bone marrow microenvironment in a subject having an impaired bone marrow microenvironment, which comprises implanting a composition comprising isolated mesenchymal stromal cells (MSCs) into the bone marrow cavity of the subject. The method of the present invention successfully remolds the bone marrow microenvironment, recovers the normal hematopoiesis of bone marrow, inhibits/delays the pathological process of leukemia and significantly prolongs the survival period. In addition, the method according to the present invention can be used for the treatment of hematologic tumors such as leukemia and aplastic anemia (AA), which is safe and effective but has no side effects.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.